Eurofins BioPharma Newsletter- October 2022
Check out the latest Eurofins BioPharma Newsletter
New Facility Grand Opening Celebration
Eurofins Viracor is proud to announce our Grand Opening Celebration event on Thursday, October 6th, 2022.
NatureMedicine 2022 article
Eurofins Viracor Biopharma credited for role in Moderna COVE Vaccine Clinical Trial.
New BioAnalysis Zone eBook
Check out this new eBook detailing key methods in clinical vaccine development on BioAnalysisZone.com
Eurofins BioPharma Newsletter- June 2022
Check out the latest BioPharma Newsletter
Seeing the Future: Announcing Our Expansion And New Facility Opening in 2022
Eurofins Viracor BioPharma is proud to announce that we have opened a state-of-the art, 110,000 sq. ft testing facility, nearly doubling our footprint in 2022.
ASGCT 25th Annual Meeting
May 16-19 2022
We’re excited to meet Gene and Cell Therapy professionals from around the world this week at #ASGCT22! Visit us at Booth #466
ON-DEMAND WEBINAR Defining Specificity within the ELISpot Assay
February 23, 2022 11 am EST
On-Demand AVAILABLE "Defining Specificity within the ELISpot Assay" Presented by TJ Beadnell, PhD, Scientific Manager, R&D.
Eurofins BioPharma Newsletter- February 2022
World Vaccine Congress- Washington DC
April 18-21 2022
Join Eurofins Viracor BioPharma at the upcoming World Vaccine Congress in Washington DC. Thomas Beadnell will be presenting on April 20th at 2:40 EST on "Specificity and Utility of ELISpot in Vaccine Clinical Development".
Connect With Our Experts
